MRK - Merck & Co., Inc.
Close
99.51
0.270 0.271%
Share volume: 114,233
Last Updated: Tue 31 Dec 2024 09:03:05 PM CET
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.56%
PREVIOUS CLOSE
CHG
CHG%
$99.24
0.27
0.27%
View ratios
| Fiscal Date | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2023-05-05 | 2023-08-07 | 2023-11-03 | 2024-02-26 | 2024-05-03 | |
| Cash flow financing | -2.054 B | 3.758 B | -4.269 B | -2.245 B | -2.814 B | |
| Other financing cash flows | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cash flow | 1.339 B | 3.704 B | 7.717 B | 246.000 M | 3.090 B | |
| Net income | 2.821 B | -5.975 B | 4.745 B | -1.226 B | 4.762 B | |
| Depreciation | 991.000 M | 903.000 M | 1.014 B | 964.000 M | 984.000 M | |
| Changes in inventories | 5.863 B | 5.930 B | 6.131 B | 6.358 B | 6.510 B | |
| Changes in receivables | 10.415 B | 11.030 B | 10.394 B | 10.349 B | 11.366 B | |
| Investing Cashflow | -2.359 B | -11.443 B | -334.000 M | 53.000 M | -1.376 B | |
| Net Borrowings | 13.622 B | 23.894 B | 19.430 B | 19.594 B | 20.650 B | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | -1.007 B | -965.000 M | -902.000 M | -989.000 M | -861.000 M | |
| Cash Change | 10.387 B | 6.378 B | 8.773 B | 7.093 B | 5.619 B |